Register for email alerts and news feeds:
This journal | BMJ Group
rss
Journal of Clinical Pathology 2004;57:189-192; doi:10.1136/jcp.2003.10660
Copyright © 2004 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.
Journal of Clinical Pathology 2004;57:189-192
© 2004 BMJ Publishing Group Ltd & Association of Clinical Pathologists

ORIGINAL ARTICLE

Gastrin releasing peptide and gastrin releasing peptide receptor expression in gastrointestinal carcinoid tumours

N Scott1, E Millward1, E J Cartwright2, S R Preston3 and P L Coletta2

1 Department of Pathology, St James’s University Hospital, United Leeds Teaching Hospitals NHS Trust, Leeds LS9 7TF, UK
2 Department of Molecular Medicine, St James’s University Hospital
3 Department of Surgery, St James’s University Hospital

Correspondence to:
Correspondence to:
Dr N Scott
Department of Pathology, St James’s University Hospital, Leeds LS9 7TF, UK; nigelscott50{at}hotmail.com

Aims: To establish whether gastrin releasing peptide (GRP) and the GRP receptor (GRPR) are expressed together in gastrointestinal carcinoid tumours.

Methods: Twenty six carcinoid tumours from the stomach, small intestine, appendix, and colorectum were investigated by immunohistochemistry for GRP and GRPR.

Results: GRP was detected in nine of 19 tumours and GRPR in 22 of 26. Coexpression of both the ligand and receptor was seen in six of 19 cases. GRPR but not GRP was more strongly expressed in appendix and colonic tumours.

Conclusions: GRP and GRPR are produced by a large number of gastrointestinal carcinoid tumours. An autocrine/paracrine pathway may exist for GRP stimulated cell proliferation in some of these neoplasms, analogous to that seen in small cell anaplastic carcinoma of the lung.

Keywords: gastrin releasing peptide; gastrin releasing peptide receptor; immunohistochemistry; carcinoid; gastrointestinal

Abbreviations: GRP, gastrin releasing peptide; GRPR, gastrin releasing peptide receptor


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Guojun, W., Wei, G., Kedong, O., Yi, H., Yanfei, X., Qingmei, C., Yankai, Z., Jie, W., Hao, F., Taiming, L., Jingjing, L., Rongyue, C. (2008). A novel vaccine targeting gastrin-releasing peptide: efficient inhibition of breast cancer growth in vivo. Endocr Relat Cancer 15: 149-159 [Abstract] [Full Text]  
  • Jensen, R. T., Battey, J. F., Spindel, E. R., Benya, R. V. (2008). International Union of Pharmacology. LXVIII. Mammalian Bombesin Receptors: Nomenclature, Distribution, Pharmacology, Signaling, and Functions in Normal and Disease States. Pharmacol. Rev. 60: 1-42 [Abstract] [Full Text]  
  • Cornelio, D., Roesler, R, Schwartsmann, G (2007). Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol 18: 1457-1466 [Abstract] [Full Text]  

eLetters:

Read all eLetters

The bombesin/GRP antagonist RC-3095 in a patient with the Zollinger-Ellison syndrome
Gilberto Schwartsmann, et al.
JCP Online, 1 Mar 2004 [Full text]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Pathology jobs

Pathology jobs